Skip to main content

Dr. Joseph Pater receives Canadian Cancer Society Lifetime Contribution Prize

CCTG Founding Director is recognized for a lifetime of work in cancer research

Dr. Joseph Pater,  is the recipient of the Canadian Cancer Society Lifetime Contribution Prize, a new honour from the Canadian Cancer Society (CCS). The award recognizes an esteemed Canadian investigator whose contributions, vision, and leadership, have enhanced the Canadian cancer research landscape to significantly benefit the lives of people with cancer.

For over 45 years, Dr. Pater has been devoted to advancing clinical trial research aimed at improving the lives of cancer patients and to educating, training, and mentoring the next generation of students, fellows, and young investigators.  Under his guidance, the Canadian Cancer Trials Group (CCTG) at Queen’s University, has become one of the most well-respected cancer clinical trials networks in the world, producing results that have accelerated the development of new treatments and established new standards of care worldwide.

“I am thrilled and humbled to be named the first recipient of the Canadian Cancer Society’s Lifetime Contribution Prize,” says Dr. Pater. “I am pleased that the selection committee has recognized my very collaborative contribution to establishing a network of Canadian research leadership who support the vital endeavour of finding the best treatments to reduce cancer morbidity and mortality, which is CCTG’s ongoing mission.”

Read more